Palmoplantar and periungual warts Skin and Connective Tissue Diseases
Conditions
Interventions
Verrutop® is topically applied on warts using a 30 µL capillary tube on each lesion until the wart changes color. Patients received Verrutop application every 2 weeks, until the wart was resolved or
Sponsors
ISDIN S.A.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Eligible patients were immunocompetent children and adolescents, with at least one palmoplantar or periungual wart suitable for topical treatment 2. Patients who had not used any other topical treatment during the previous month
Exclusion criteria
Exclusion criteria: 1. Pregnancy or lactation 2. Received previous treatments interfering with the evaluation of the warts during 30 days previous to be included in the study
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Number of sessions needed for complete disappearance of warts 2. Physician’s global satisfaction evaluation 3. Physician and patient's evaluation of esthetic results 4. Tolerability of treatment | — |
Primary
| Measure | Time frame |
|---|---|
| Clearance of warts assessed by a dermatologist at the clinical site during all study visits and at the end of treatment. Complete clearance of verruca will be defined as the restoration of normal skin upon close inspection. | — |
Countries
Spain
Contacts
Public ContactJavier Bustos
Outcome results
None listed